Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | -3.60% | 55.96 | 0.0% | $456.84m | |
| HZNP | Horizon Therapeutics Plc | -0.35% | 104.50 | 5.4% | $199.74m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -3.22% | 25.27 | 14.1% | $148.69m | |
| CTLT | Catalent, Inc. | 2.17% | 132.40 | 2.0% | $130.81m | |
| ICLR | ICON plc | -0.68% | 272.00 | 2.8% | $116.32m | |
| UTHR | United Therapeutics Corp. | -3.27% | 193.64 | 13.9% | $83.25m | |
| BHC | Bausch Health Cos., Inc. | -3.22% | 25.27 | 0.0% | $75.17m | |
| JAZZ | Jazz Pharmaceuticals Plc | -4.04% | 124.09 | 2.1% | $63.68m | |
| PRGO | Perrigo Co. Plc | -2.68% | 37.79 | 6.9% | $58.52m | |
| ARGX | argenx SE | -0.29% | 276.10 | 0.0% | $52.50m | |
| ENDP | Endo International Plc | -3.64% | 5.83 | 8.5% | $52.32m | |
| AXSM | Axsome Therapeutics, Inc. | -2.66% | 36.92 | 1.8% | $26.01m | |
| QLGN | Qualigen Therapeutics, Inc. | -2.86% | 1.70 | 0.0% | $23.79m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | -3.63% | 11.16 | 9.5% | $23.37m | |
| ORMP | Oramed Pharmaceuticals, Inc. | 6.82% | 20.21 | 0.5% | $22.64m |
Company Profile
Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.